Total Payments
$2,458
2024 Payments
$2,078
Companies
41
Transactions
113
Medicare Patients
100
Medicare Billing
$9,588
Payment Breakdown by Category
Food & Beverage$2,062 (83.9%)
Education$396.02 (16.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,062 | 108 | 83.9% |
| Education | $396.02 | 5 | 16.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $241.45 | 12 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $238.47 | 4 | $0 (2024) |
| Incyte Corporation | $158.11 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $151.18 | 7 | $0 (2024) |
| SOBI, INC | $148.50 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $116.22 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $116.18 | 7 | $0 (2024) |
| SEAGEN INC. | $114.64 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $109.12 | 5 | $0 (2024) |
| Eisai Inc. | $89.16 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,078 | 95 | PFIZER INC. ($241.45) |
| 2023 | $379.34 | 18 | Rigel Pharmaceuticals, Inc. ($98.27) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.94 | General |
| 12/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/04/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/22/2024 | PFIZER INC. | BRAFTOVI (Drug), MEKTOVI | Education | In-kind items and services | $13.04 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Oncology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $17.97 | General |
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.93 | General |
| Category: Oncology | ||||||
| 11/08/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $25.02 | General |
| 11/05/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $14.05 | General |
| 10/30/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Oncology | ||||||
| 10/24/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/23/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 40 | 66 | $12,945 | $3,740 |
| 2022 | 2 | 60 | 97 | $27,348 | $5,848 |
Total Patients
100
Total Services
163
Medicare Billing
$9,588
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 36 | $5,613 | $2,373 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 24 | 30 | $7,332 | $1,367 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 34 | 65 | $15,860 | $3,320 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 26 | 32 | $11,488 | $2,528 | 22.0% |
About Dr. Minesh Nandi, MD
Dr. Minesh Nandi, MD is a Hematology & Oncology healthcare provider based in Hiram, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2017. The National Provider Identifier (NPI) number assigned to this provider is 1306376421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Minesh Nandi, MD has received a total of $2,458 in payments from pharmaceutical and medical device companies, with $2,078 received in 2024. These payments were reported across 113 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($2,062).
As a Medicare-enrolled provider, Nandi has provided services to 100 Medicare beneficiaries, totaling 163 services with total Medicare billing of $9,588. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Internal Medicine
- Location Hiram, GA
- Active Since 06/13/2017
- Last Updated 10/29/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1306376421
Products in Payments
- Rezlidhia (Drug) $238.47
- KEYTRUDA (Biological) $151.18
- DOPTELET (Drug) $148.50
- Lenvima (Drug) $89.16
- Padcev (Drug) $76.70
- JAKAFI (Drug) $59.11
- VERZENIO (Drug) $53.27
- IBRANCE (Drug) $51.69
- OPDIVO (Biological) $51.06
- BRAFTOVI (Drug) $48.92
- CABOMETYX (Drug) $46.87
- REBLOZYL (Biological) $46.73
- Optune (Device) $40.58
- MEKINIST (Drug) $37.34
- Enhertu (Drug) $36.89
- PROMACTA (Drug) $34.18
- OJJAARA (Drug) $32.89
- KRAZATI (Drug) $32.42
- ENHERTU (Biological) $32.26
- INLYTA (Drug) $31.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.